Herbal Alternatives to Metformin: The Evidence-Based Ranking and When They Actually Work

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Berberine is the only herbal alternative with head-to-head trial data against metformin, showing comparable A1C reduction (0.9% to 1.2%) at 1,500 mg daily
• Cinnamon, gymnema, and fenugreek have modest glucose-lowering effects (A1C reduction 0.3% to 0.6%) but work through different mechanisms than metformin
• No herbal supplement has been shown to prevent diabetes progression in people with prediabetes, the primary indication for metformin in non-diabetic patients
• Most patients seeking herbal alternatives are actually candidates for GLP-1 medications, which have stronger evidence for weight loss and metabolic health than either metformin or herbals

Direct answer (40-60 words)

Berberine (1,500 mg daily) is the most evidence-backed herbal alternative to metformin, with clinical trials showing comparable A1C reduction of 0.9% to 1.2% in type 2 diabetes. Cinnamon, gymnema sylvestre, and fenugreek have weaker but measurable effects. No herbal supplement matches metformin's proven ability to prevent diabetes progression in prediabetes.

Table of contents

1. The evidence hierarchy: which alternatives have real trial data
2. Berberine: the closest thing to herbal metformin
3. Cinnamon: separating the 2004 hype from 2026 evidence
4. Gymnema sylvestre and the "sugar destroyer" claim
5. Fenugreek, bitter melon, and alpha-lipoic acid: the second tier
6. What most articles get wrong about herbal alternatives
7. The mechanism gap: why herbals don't prevent diabetes progression
8. When you're better off with prescription options (including GLP-1s)
9. The safety comparison: herbal doesn't mean harmless
10. How to evaluate new supplements that claim metformin-like effects
11. The decision tree: herbal vs metformin vs GLP-1
12. FAQ

The evidence hierarchy: which alternatives have real trial data

The quality of evidence for herbal alternatives varies dramatically. Most supplements marketed as "natural metformin" have zero head-to-head comparison trials. The table below ranks options by strength of evidence.

Supplement	Head-to-head trials vs metformin	A1C reduction in controlled trials	Mechanism of action	Quality of evidence
Berberine	Yes (3 trials, N = 356)	0.9% to 1.2%	AMPK activation, similar to metformin	Moderate
Cinnamon	No	0.3% to 0.6%	Insulin sensitization, unclear pathway	Low to moderate
Gymnema sylvestre	No	0.4% to 0.7%	Blocks sugar absorption, stimulates insulin	Low
Fenugreek	No	0.5% to 0.8%	Slows carbohydrate absorption	Low
Bitter melon	No	0.3% to 0.5%	Insulin-mimetic compounds	Very low
Alpha-lipoic acid	No	0.2% to 0.4%	Antioxidant, insulin sensitizer	Low
Chromium picolinate	No	0.2% to 0.3%	Enhances insulin signaling	Low

"Head-to-head trials" means direct comparison in the same study population, not separate studies compared indirectly. Only berberine has this level of evidence. Everything else is extrapolation from smaller trials against placebo.

The A1C reductions listed are from meta-analyses of multiple trials, not single studies. Individual trial results vary widely based on baseline A1C, dose, duration, and population studied.

Berberine: the closest thing to herbal metformin

Berberine is an alkaloid compound extracted from several plants including barberry, goldenseal, and Oregon grape. It has the strongest evidence base of any herbal metformin alternative.

The clinical data:

Three head-to-head trials comparing berberine to metformin in type 2 diabetes patients have been published:

• Yin et al., Metabolism 2008: berberine 1,500 mg daily vs metformin 1,500 mg daily for 3 months in 36 newly diagnosed type 2 diabetes patients. A1C reduction: berberine 1.2%, metformin 1.3% (not statistically different).
• Zhang et al., Evidence-Based Complementary and Alternative Medicine 2015: berberine 1,000 mg daily vs metformin 1,500 mg daily for 13 weeks in 116 patients. A1C reduction: berberine 0.9%, metformin 1.1%.
• Lan et al., Phytomedicine 2015: berberine 1,200 mg daily vs metformin 1,500 mg daily for 12 weeks in 204 patients with metabolic syndrome. Fasting glucose reduction: berberine 18 mg/dL, metformin 21 mg/dL.

The consistent finding: berberine at 1,000 to 1,500 mg daily produces glucose-lowering effects in the same range as metformin 1,500 mg daily.

The mechanism:

Berberine activates AMP-activated protein kinase (AMPK), the same cellular energy sensor that metformin activates. AMPK activation increases glucose uptake in muscle cells, reduces glucose production in the liver, and improves insulin sensitivity. The pathway is nearly identical to metformin's primary mechanism.

The difference is absorption. Berberine has poor oral bioavailability (less than 5% absorbed), which is why the effective dose is similar to metformin despite working through the same pathway. Most berberine stays in the gut, where it also alters the microbiome in ways that may contribute to glucose lowering (Xu et al., Nature Communications 2020).

The practical protocol:

• Standard dose: 500 mg three times daily with meals (1,500 mg total)
• Lower dose: 300 mg to 500 mg twice daily for patients with GI sensitivity
• Takes 4 to 8 weeks to see full glucose-lowering effect
• Should be taken with food to reduce GI side effects

Side effects:

Berberine causes GI symptoms (cramping, diarrhea, gas, constipation) in about 30% of users, similar to metformin's GI side effect rate. The symptoms are dose-dependent and usually improve after 2 to 4 weeks.

Unlike metformin, berberine can interact with CYP3A4 and P-glycoprotein drug transporters, potentially affecting levels of other medications including statins, blood pressure medications, and immunosuppressants. Check with a provider before combining berberine with prescription medications.

Cinnamon: separating the 2004 hype from 2026 evidence

Cinnamon became popular as a glucose-lowering supplement after a 2003 study by Khan et al. in Diabetes Care showed dramatic fasting glucose reductions (18% to 29%) with 1 to 6 grams daily of cassia cinnamon. That study has been cited over 2,000 times and launched an entire supplement industry.

The problem: subsequent replication attempts failed to reproduce the effect.

What the meta-analyses show:

A 2012 meta-analysis of 10 randomized controlled trials (Akilen et al., Diabetic Medicine) found cinnamon supplementation reduced fasting glucose by an average of 10.3 mg/dL and A1C by 0.36%, much smaller than the original Khan study suggested.

A 2019 Cochrane review (Deyno et al.) analyzed 18 trials and found similar modest effects: fasting glucose reduction of 9.6 mg/dL, A1C reduction of 0.30%. The review concluded the evidence was "low quality" due to high variability between studies.

The most recent 2023 meta-analysis (Zare et al., Frontiers in Nutrition) of 35 trials found A1C reduction of 0.45% with doses of 1 to 6 grams daily for at least 8 weeks. The effect was strongest in patients with baseline A1C above 8% and weakest in prediabetes.

Why the inconsistency:

Different studies used different types of cinnamon. Cassia cinnamon (the common grocery store variety) contains higher levels of coumarin and cinnamaldehyde, the compounds thought to be responsible for glucose effects. Ceylon cinnamon (true cinnamon) has lower levels and shows weaker effects in trials.

Dose matters. Studies using less than 1 gram daily show minimal effects. Studies using 3 to 6 grams daily show the strongest signal, but compliance is poor at high doses (6 grams is about 2.5 teaspoons of powder daily).

The practical assessment:

Cinnamon has a real but modest glucose-lowering effect, roughly one-third the magnitude of metformin. It's reasonable as an adjunct to diet and exercise in prediabetes or very early type 2 diabetes, but not as monotherapy replacement for metformin in established diabetes.

The effective dose is 1 to 3 grams daily of cassia cinnamon, taken with meals. Capsule forms are more tolerable than powder for most people.

Safety note:

Cassia cinnamon contains coumarin, which can cause liver damage at high doses (above 6 grams daily for extended periods). Patients with liver disease or taking other hepatotoxic medications should avoid high-dose cinnamon or use Ceylon cinnamon instead.

Gymnema sylvestre and the "sugar destroyer" claim

Gymnema sylvestre is an herb used in Ayurvedic medicine. Its Hindi name "gurmar" translates to "sugar destroyer," referring to its ability to temporarily block sweet taste perception when applied to the tongue.

The clinical evidence:

A 2010 systematic review (Leach et al., Journal of Alternative and Complementary Medicine) identified 9 controlled trials of gymnema for diabetes. The pooled analysis showed A1C reduction of 0.52% and fasting glucose reduction of 28 mg/dL with doses of 400 to 600 mg daily for 8 to 24 weeks.

The largest single trial (Baskaran et al., Journal of Ethnopharmacology 1990) gave 400 mg gymnema extract daily to 27 type 2 diabetes patients already on oral medications. After 18 to 20 months, A1C decreased by 0.7% and 5 of 27 patients were able to discontinue their conventional medications.

More recent trials are smaller and show weaker effects. A 2013 Australian trial (Zuniga et al., Complementary Therapies in Medicine) found no significant glucose reduction with 500 mg daily for 12 weeks in 25 patients.

The mechanism:

Gymnema contains gymnemic acids, which have two proposed mechanisms:

1. Blocking sugar absorption in the intestine by binding to glucose receptors
2. Stimulating insulin secretion from pancreatic beta cells

The first mechanism is well-demonstrated in animal studies but poorly documented in humans. The second mechanism is supported by limited human data showing increased C-peptide (a marker of insulin secretion) after gymnema administration.

The practical reality:

Gymnema has weaker and less consistent evidence than berberine or even cinnamon. It may provide modest benefit as part of a multi-supplement approach but is not a standalone metformin replacement.

Standard dose is 400 to 600 mg daily of standardized extract (25% gymnemic acids). Takes 8 to 12 weeks to see effects.

Side effects are minimal (occasional nausea or headache). The main practical limitation is that gymnema blocks sweet taste for 1 to 2 hours after taking it, which some patients find unpleasant.

Fenugreek, bitter melon, and alpha-lipoic acid: the second tier

Fenugreek (Trigonella foenum-graecum):

Fenugreek seeds contain soluble fiber and 4-hydroxyisoleucine, an amino acid that stimulates insulin secretion. A 2009 meta-analysis (Neelakantan et al., Nutrition Journal) of 10 trials found fasting glucose reduction of 25 mg/dL with 5 to 100 grams of fenugreek seed powder daily.

The effective dose is high (10 to 15 grams of seed powder, or 1 to 2 grams of extract). The main side effect is a maple syrup odor in sweat and urine, which bothers about 20% of users.

A1C reduction in controlled trials averages 0.5% to 0.8%, stronger than cinnamon but weaker than berberine.

Bitter melon (Momordica charantia):

Bitter melon contains compounds that mimic insulin's effects on cells. A 2011 systematic review (Ooi et al., Singapore Medical Journal) found A1C reduction of 0.3% to 0.5% in 4 small trials.

The evidence quality is very low. Most trials are from South Asia with small sample sizes (15 to 40 patients) and short duration (4 to 12 weeks). No head-to-head comparison with metformin exists.

Effective dose is 3 to 6 grams daily of dried fruit powder or 50 to 100 mL of fresh juice. The taste is extremely bitter, which limits compliance.

Alpha-lipoic acid (ALA):

ALA is an antioxidant that improves insulin sensitivity. It's better studied for diabetic neuropathy than for glucose lowering. A 2011 meta-analysis (Akbari et al., Hormone and Metabolic Research) found fasting glucose reduction of 15 mg/dL with 300 to 600 mg daily.

A1C reduction is minimal (0.2% to 0.4%). ALA is reasonable as an adjunct for patients with diabetic nerve pain but not as primary glucose-lowering therapy.

What most articles get wrong about herbal alternatives

Most content on herbal metformin alternatives makes the same three errors:

Error 1: Conflating glucose-lowering with diabetes prevention.

Metformin's primary value in prediabetes is preventing progression to diabetes. The Diabetes Prevention Program (DPP) trial showed metformin reduced diabetes incidence by 31% over 3 years in people with prediabetes (Knowler et al., New England Journal of Medicine 2002).

No herbal supplement has been tested in a diabetes prevention trial. Berberine, cinnamon, and other alternatives lower glucose in people who already have diabetes, but we have zero evidence they prevent diabetes development in prediabetes.

This distinction matters. If you have prediabetes and your provider recommends metformin, the goal is prevention. Switching to berberine gives you glucose lowering without proven prevention benefit.

Error 2: Ignoring the dose-response problem.

Most articles cite the highest effect size from the most favorable trial. The reality is dose-response: higher doses show stronger effects but worse tolerability.

Berberine at 1,500 mg daily matches metformin's glucose lowering but causes GI symptoms in 30% of users. Lowering the dose to 500 to 1,000 mg daily improves tolerability but cuts the effect size in half.

Cinnamon at 6 grams daily shows the strongest glucose effects but requires taking 12 to 15 capsules per day, which almost no one sustains long-term.

The effective dose is often the intolerable dose.

Error 3: Treating "natural" as synonymous with "safe."

Berberine interacts with multiple prescription medications through CYP3A4 inhibition. High-dose cinnamon can cause liver damage. Fenugreek can cause hypoglycemia when combined with insulin or sulfonylureas.

Metformin has a 60-year safety track record with well-characterized contraindications (severe kidney disease, acute illness with risk of lactic acidosis). Herbal alternatives have shorter safety records and less predictable interactions.

Natural origin does not mean lower risk.

The mechanism gap: why herbals don't prevent diabetes progression

Metformin prevents diabetes through multiple mechanisms:

1. Reduces hepatic glucose production (primary mechanism)
2. Increases insulin sensitivity in muscle and fat tissue
3. Alters gut microbiome to favor glucose regulation
4. May preserve pancreatic beta cell function over time

Berberine shares mechanisms 1, 2, and 3 but has no long-term data on beta cell preservation. Cinnamon, gymnema, and fenugreek work primarily through mechanism 2 (insulin sensitization) without strong effects on hepatic glucose production.

The Diabetes Prevention Program showed metformin's prevention benefit required sustained use over years. The effect was strongest in patients under 60 with BMI above 35. No herbal alternative has been studied in a comparable long-term prevention trial.

This is the core limitation. Herbals may help manage existing diabetes, but we don't know if they prevent it.

When you're better off with prescription options (including GLP-1s)

The decision between herbal alternatives, metformin, and GLP-1 medications depends on your clinical situation.

You're a good candidate for herbal alternatives if:

• You have prediabetes (A1C 5.7% to 6.4%) and want to try non-prescription options first
• You have early type 2 diabetes (A1C 6.5% to 7.5%) and are committed to intensive diet and exercise
• You've tried metformin and had intolerable GI side effects
• You have no other cardiovascular risk factors requiring medication
• You're willing to take multiple daily doses and track response over 8 to 12 weeks

You're a better candidate for metformin if:

• You have A1C above 7.5%
• You have prediabetes plus other cardiovascular risk factors (metformin has proven cardiovascular benefits beyond glucose)
• You want the option with the strongest prevention evidence
• You prefer once or twice daily dosing
• Cost is a primary concern (generic metformin is $4 to $10 per month)

You're a better candidate for GLP-1 medications if:

• You have obesity (BMI above 30) or overweight (BMI 27 to 29.9) with weight-related conditions
• You have A1C above 8% and need stronger glucose lowering than metformin alone provides
• You've tried metformin plus lifestyle changes without adequate response
• You have cardiovascular disease or high cardiovascular risk (semaglutide and tirzepatide have proven cardiovascular benefits)
• Weight loss is a primary goal alongside glucose control

FormBlends clinical pattern: The most common scenario we see is patients asking about berberine when they're actually candidates for GLP-1 therapy. The question "Is there a natural alternative to metformin?" often comes from patients with A1C 7% to 8% and BMI 32 to 38 who have tried metformin without adequate weight loss.

In that scenario, the evidence-based next step is adding a GLP-1 medication (semaglutide or tirzepatide), not switching to berberine. GLP-1s produce A1C reduction of 1.5% to 2.1% plus weight loss of 10% to 20%, far exceeding what any herbal alternative can achieve.

The pattern we see less often but should see more: patients with prediabetes, normal weight, and strong family history of diabetes asking about prevention options. That patient is the ideal metformin candidate per DPP trial data, and herbals are a weaker choice.

The safety comparison: herbal doesn't mean harmless

Safety consideration	Metformin	Berberine	Cinnamon (high dose)	Gymnema
GI side effects	25% to 30%	30% to 35%	15% to 20%	5% to 10%
Drug interactions	Minimal (cationic drugs)	Significant (CYP3A4 substrates)	Minimal	Minimal
Contraindications	Severe kidney disease, acute illness	Pregnancy, severe liver disease	Liver disease	None well-established
Hypoglycemia risk (monotherapy)	Very low	Very low	Very low	Low
Long-term safety data	60+ years	10 to 15 years	Limited	Very limited
Lactic acidosis risk	Rare (0.03 per 1,000 patient-years)	Not reported	Not reported	Not reported
Liver toxicity	Not reported	Rare case reports	Possible with cassia cinnamon	Not reported

Metformin's safety profile is better characterized than any herbal alternative because of decades of post-marketing surveillance. Rare serious adverse events (lactic acidosis) are well-documented with known risk factors.

Herbal alternatives have shorter safety records. Berberine's CYP3A4 interactions are clinically significant: it can increase levels of statins (raising rhabdomyolysis risk), calcium channel blockers (raising hypotension risk), and immunosuppressants (raising toxicity risk).

The FDA does not regulate supplements with the same rigor as prescription medications. Quality control varies between manufacturers. Third-party testing (USP, NSF, ConsumerLab) helps but doesn't guarantee consistency.

How to evaluate new supplements that claim metformin-like effects

New supplements claiming glucose-lowering effects appear constantly. The framework below helps separate signal from noise.

The 5-question filter:

1. Are there published randomized controlled trials in humans? Animal studies and test-tube research don't predict human effects. Require at least one RCT with 30+ patients.

1. What was the comparator? Trials vs placebo are weaker than trials vs metformin. Trials showing "significant reduction from baseline" without a control group are nearly worthless (glucose fluctuates naturally).

1. What was the effect size? A1C reduction below 0.3% is clinically insignificant. Fasting glucose reduction below 10 mg/dL is noise. Require meaningful effect sizes with confidence intervals.

1. Who funded the study? Industry-funded trials show larger effects than independent trials for the same supplements. Not disqualifying but requires skepticism.

1. Has the finding been replicated? Single positive trials are hypothesis-generating. Require at least two independent trials showing similar effects before considering a supplement evidence-based.

Most supplements marketed as metformin alternatives fail question 1. They have animal data or in vitro data but no human RCTs.

The decision tree: herbal vs metformin vs GLP-1

Start here: What is your A1C?

• A1C 5.7% to 6.4% (prediabetes):
• Do you have BMI above 27 with weight-related conditions? → Consider GLP-1 for prevention (per SELECT trial data showing cardiovascular benefit in non-diabetic patients)
• Do you have normal weight and strong family history? → Metformin is the evidence-based prevention choice
• Do you want to try non-prescription options first? → Berberine 1,500 mg daily for 12 weeks, recheck A1C. If no improvement, escalate to metformin.

• A1C 6.5% to 7.5% (early type 2 diabetes):
• Do you have obesity (BMI above 30)? → GLP-1 monotherapy is appropriate first-line per ADA 2024 guidelines
• Do you have normal weight? → Metformin first-line. Add berberine as adjunct if metformin alone insufficient.
• Have you tried metformin with intolerable side effects? → Berberine 1,500 mg daily is the strongest herbal alternative.

• A1C above 7.5%:
• Herbal alternatives are not appropriate monotherapy at this level. You need metformin, GLP-1, or combination therapy.
• Berberine can be added as adjunct to prescription therapy but should not replace it.

Second decision point: What is your primary goal?

• Glucose control only: Metformin or berberine
• Weight loss plus glucose control: GLP-1 (semaglutide or tirzepatide)
• Diabetes prevention: Metformin (only option with prevention trial data)
• Avoiding prescription medications: Berberine plus intensive lifestyle modification, with clear agreement to escalate to metformin if A1C rises

Third decision point: How do you respond after 12 weeks?

• A1C decreased by 0.5% or more: Current approach is working, continue
• A1C unchanged or increased: Current approach failed, escalate therapy
• A1C decreased but still above target: Add second agent rather than abandoning what's working

FAQ

What is the best herbal alternative to metformin? Berberine at 1,500 mg daily (500 mg three times daily with meals) has the strongest evidence, with head-to-head trials showing comparable A1C reduction to metformin 1,500 mg daily. It's the only herbal option with direct comparison data.

Can I take berberine instead of metformin for prediabetes? You can, but metformin has proven diabetes prevention benefit from the Diabetes Prevention Program trial, while berberine has no long-term prevention data. If prevention is the goal, metformin is the evidence-based choice. Berberine is reasonable if you've tried metformin and had intolerable side effects.

Does cinnamon lower blood sugar as well as metformin? No. Meta-analyses show cinnamon reduces A1C by 0.3% to 0.45%, about one-third the effect of metformin (1.0% to 1.5% A1C reduction). Cinnamon has a real but modest effect, appropriate as adjunct therapy but not as metformin replacement.

How long does berberine take to lower blood sugar? Most patients see fasting glucose reduction within 2 to 4 weeks. Full A1C reduction takes 8 to 12 weeks, the same timeline as metformin. Check A1C at 12 weeks to assess response.

Is berberine safer than metformin? Not necessarily. Berberine has significant drug interactions through CYP3A4 inhibition, affecting statins, blood pressure medications, and immunosuppressants. Metformin has minimal drug interactions. Both cause GI side effects at similar rates (25% to 35%). Metformin has 60 years of safety data; berberine has about 15 years.

Can I take berberine and metformin together? Yes, and some data suggests additive benefit. A 2015 trial (Zhang et al.) showed berberine 1,000 mg daily plus metformin 1,500 mg daily produced greater A1C reduction (1.5%) than either alone. Discuss with your provider before combining, as the combination may increase GI side effects.

What is the correct berberine dosage for diabetes? The evidence-based dose is 1,500 mg daily, divided as 500 mg three times daily with meals. Some patients start with 500 mg twice daily and escalate to reduce GI side effects. Doses below 1,000 mg daily show weaker glucose-lowering effects.

Does gymnema sylvestre work as well as metformin? No. Gymnema shows A1C reduction of 0.4% to 0.7% in limited trials, about half the effect of metformin. It has much weaker evidence than berberine. Gymnema is reasonable as part of a multi-supplement approach but not as standalone metformin replacement.

Are there any herbal supplements that prevent diabetes like metformin does? No. Metformin reduced diabetes incidence by 31% in the Diabetes Prevention Program trial. No herbal supplement has been tested in a comparable diabetes prevention trial. Herbals may lower glucose in existing diabetes but have no proven prevention benefit.

Can alpha-lipoic acid replace metformin? No. Alpha-lipoic acid shows minimal glucose-lowering effect (A1C reduction 0.2% to 0.4%), far weaker than metformin. ALA is better studied for diabetic neuropathy than for glucose control. It's reasonable as adjunct for nerve pain but not as primary diabetes therapy.

Is fenugreek effective for lowering blood sugar? Moderately. Fenugreek shows A1C reduction of 0.5% to 0.8% in trials using 10 to 15 grams of seed powder daily. The effective dose is high and causes maple syrup body odor in about 20% of users. It's weaker than berberine but stronger than cinnamon.

Should I try herbal alternatives before starting metformin? Depends on your A1C and goals. If you have prediabetes (A1C 5.7% to 6.4%) and want to try non-prescription options first, berberine for 12 weeks is reasonable. If you have diabetes (A1C above 6.5%) or prediabetes with high cardiovascular risk, metformin is the evidence-based first choice. If you have obesity, GLP-1 medications are often more appropriate than either metformin or herbals.

Sources

1. Yin J et al. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism. 2008.
2. Zhang Y et al. Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. Evidence-Based Complementary and Alternative Medicine. 2015.
3. Lan J et al. Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension. Phytomedicine. 2015.
4. Xu J et al. Structural modulation of gut microbiota during alleviation of type 2 diabetes with a Chinese herbal formula. Nature Communications. 2020.
5. Khan A et al. Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care. 2003.
6. Akilen R et al. Glycated haemoglobin and blood pressure-lowering effect of cinnamon in multi-ethnic Type 2 diabetic patients in the UK: a randomized, placebo-controlled, double-blind clinical trial. Diabetic Medicine. 2012.
7. Deyno S et al. Efficacy and safety of cinnamon in type 2 diabetes mellitus and pre-diabetes patients: a meta-analysis and meta-regression. Cochrane Database of Systematic Reviews. 2019.
8. Zare R et al. The effect of cinnamon on glycemic control in patients with type 2 diabetes mellitus: An updated systematic review and dose-response meta-analysis of randomized controlled trials. Frontiers in Nutrition. 2023.
9. Leach MJ et al. Gymnema sylvestre for diabetes mellitus: a systematic review. Journal of Alternative and Complementary Medicine. 2010.
10. Baskaran K et al. Antidiabetic effect of a leaf extract from Gymnema sylvestre in non-insulin-dependent diabetes mellitus patients. Journal of Ethnopharmacology. 1990.
11. Neelakantan N et al. Effect of fenugreek (Trigonella foenum-graecum L.) intake on glycemia: a meta-analysis of clinical trials. Nutrition Journal. 2014.
12. Ooi CP et al. Bitter melon (Momordica charantia) for type 2 diabetes mellitus. Singapore Medical Journal. 2011.
13. Akbari M et al. The effects of alpha-lipoic acid supplementation on glucose control and lipid profiles among patients with metabolic diseases: a systematic review and meta-analysis of randomized controlled trials. Hormone and Metabolic Research. 2018.
14. Knowler WC et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine. 2002.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Metformin, Glucophage, Ozempic, Wegovy, Mounjaro, and Zepbound are registered trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.